Aprea Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Business model:
B2B
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 3 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Aprea Therapeutics is a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein

Companies with similar profile to Aprea Therapeutics:

CompanyCriteria
Sweden Modus Therapeutics
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Rosetta Capital, HealthCap
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden BoneSupport
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Rosetta Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Mobidiag
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Galecto Biotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Chundsell Medicals
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland TILT Biotherapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark MinervaX
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Athera
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
Norway Mentis Cura
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Scandinavian Real Hearts
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Synoste Oy
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes